4.7 Review

Epigenetics of Epstein Barr virus - A review

Publisher

ELSEVIER
DOI: 10.1016/j.bbadis.2023.166838

Keywords

Epstein Barr virus; Latent genes; Lytic reactivation; DNA methylation; Epigenetics; Biomarkers

Ask authors/readers for more resources

Epstein Barr virus (EBV) is the first oncogenic virus in humans and is closely associated with various lymphoproliferative and malignant diseases. EBV has a biphasic viral life cycle, consisting of a latent period and lytic replication, with B-cells playing a critical role in latent gene expression and immune recognition evasion. Dysregulation of epigenetic regulation, particularly DNA methylation, in both viral and host genome expression, is closely related to carcinogenesis and long-lasting phenotypes in malignancies.
Epstein Barr is the first-in-human oncogenic virus, closely related to numerous lymphoproliferative and malignant diseases, including HL, BL, NPC, and GC. EBV establishes life-long persistence infection portraying a biphasic viral life cycle: latent period and lytic replication. B-cells serve as critical regions for EBV latent genes, wherein viral gene expression is suppressed, promoting viral genome maintenance and immune recognition evasion. Upon its lytic reactivation, viral gene expression induces its replication, progeny production, and transmission. Dysregulations of epigenetic regulation in expressions of TSGs lead to carcinogenesis. Several studies reveal that EBV is associated with aberrant viral DNA and host genome methylation patterns, promoting immune monitoring, recognition evasiveness and host cell persistence. Among other epigenetic modifications, DNA methylation suppresses the majority of viral latent gene promoters, sparing a few, and acts as a prerequisite for activating EBV's lytic cycle, giving rise to viral progeny. It affects the host's epigenome via reprogramming cells to oncogenic, long-lasting phenotypes, as evident in several malignancies. At each phase of its life cycle, EBV exploits cellular mechanisms of epigenetic regulation, implying its unique host-pathogen relationship. This review summarized the DNA methylation's regulatory roles on several EBV-related promoter regions, along with the host genome in pathological conditions, highlights viral genes involved in a latent, lytic and latent-lytic phase of EBV infection. Moreover, it provides diagrammatic insights into methylation-based pathways in EBV.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available